Trovagene Inc (TROV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7333
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trovagene Inc (Trovagene) is a clinical-stage cancer therapeutics company that focuses on improved cancer care using its technology in tumor genomics. Its lead product, PCM-075, is a polo-like kinase 1 (PLK1) inhibitor that helps treat solid tumor cancers and multiple hematologic malignancies. The company’s pipeline products include TROV-052 for the treatment of acute myeloid leukemia; and TROV-053 for the treatment of castration-resistant prostate cancer. Trovagene harnesses its proprietary Precision Cancer Monitoring (PCM) technology to analyze circulating tumor DNA (ctDNA) and clinically actionable markers for the detection and quantitation of oncogene mutations, which enable it to discover patients with possibility to respond to targeted cancer therapies. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc (TROV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Trovagene Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
Venture Financing 14
TrovaGene Secures USD15 Million in Venture Funding 14
Partnerships 15
Trovagene Enters Into Licensing Agreement with GenSignia IP 15
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 16
Trovagene Enters into Agreement with Novogene 17
Trovagene Enters into Agreement for Trovera 18
Trovagene Enters into Agreement with AstraZeneca 19
Trovagene Enter into Agreements for Trovera 20
Trovagene Enters into Agreement with Boreal Genomics 21
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 22
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 23
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 24
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 25
Equity Offering 26
Trovagene Raises USD18 Million in Public Offering of Shares 26
Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants 28
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 30
Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants 31
Trovagene Raises USD40.3 Million in Public Offering of Shares 32
Trovagene Completes Public Offering of Shares for USD23 Million 34
Trovagene Completes Private Placement Of Shares For US$15 Million 35
Trovagene Completes Private Placement Of Units For US$4 Million 36
Trovagene Completes Exercise Of Underwriters’ Option For Public Offering Of Units For US$10.6 Million 37
Trovagene Inc – Key Competitors 38
Trovagene Inc – Key Employees 39
Trovagene Inc – Locations And Subsidiaries 40
Head Office 40
Recent Developments 41
Financial Announcements 41
Aug 03, 2018: Trovagene announces second quarter 2018 highlights and financial results 41
May 08, 2018: Trovagene Announces First Quarter 2018 Highlights and Financial Results 43
Feb 26, 2018: Trovagene Announces Fourth Quarter and Full-Year 2017 Results 44
Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results 46
Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 48
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 50
Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 52
Corporate Communications 53
Jun 22, 2018: Trovagene Announces Senior Management Change 53
Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 54
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 55
Legal and Regulatory 57
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 57
Product News 58
Jan 03, 2018: Trovagene to Present at the Biotech Showcase Annual Conference 58
Other Significant Developments 59
Jul 12, 2017: Trovagene Announces Agreement with Novogene for NextCollect in China 59
Jun 22, 2017: Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials 60
Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Trovagene Inc, Medical Equipment, Key Facts, 2017 2
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Trovagene Inc, Deals By Market, 2012 to YTD 2018 9
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
TrovaGene Secures USD15 Million in Venture Funding 14
Trovagene Enters Into Licensing Agreement with GenSignia IP 15
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 16
Trovagene Enters into Agreement with Novogene 17
Trovagene Enters into Agreement for Trovera 18
Trovagene Enters into Agreement with AstraZeneca 19
Trovagene Enter into Agreements for Trovera 20
Trovagene Enters into Agreement with Boreal Genomics 21
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 22
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 23
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 24
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 25
Trovagene Raises USD18 Million in Public Offering of Shares 26
Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants 28
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 30
Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants 31
Trovagene Raises USD40.3 Million in Public Offering of Shares 32
Trovagene Completes Public Offering of Shares for USD23 Million 34
Trovagene Completes Private Placement Of Shares For US$15 Million 35
Trovagene Completes Private Placement Of Units For US$4 Million 36
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 37
Trovagene Inc, Key Competitors 38
Trovagene Inc, Key Employees 39

List of Figures
Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Trovagene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Trovagene Inc (TROV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sensus BV:企業の戦略・SWOT・財務情報
    Sensus BV - Strategy, SWOT and Corporate Finance Report Summary Sensus BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Tundra Oil & Gas Partnership:石油・ガス:M&Aディール及び事業提携情報
    Summary Tundra Oil & Gas Partnership (Tundra), a subsidiary of James Richardson & Sons, Limited is an oil and gas company that offers asset development services. The company produces and markets light sweet crude oil in southeastern Saskatchewan and southwestern Manitoba. It explores and produces na …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biosense Webster Inc-医療機器分野:企業M&A・提携分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson is a medical device company that offers cardiac arrhythmias products. The company designs, manufactures and markets products for diagnosis and treatment of cardiac arrhythmias. Its products comprise ablation catheters …
  • The Hour Glass Ltd (AGS):企業の財務・戦略的SWOT分析
    The Hour Glass Ltd (AGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Navistar International Corporation (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cumberland Pharmaceuticals Inc (CPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a pharmaceutical company which develops and commercializes branded prescription products. The company’s product portfolio includes acetylcysteine, ibuprofen, lactulose, conivaptan, amifostine and ifetroban. It provides prescription produc …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務情報
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • DMC Global Inc (BOOM):企業の財務・戦略的SWOT分析
    Summary DMC Global Inc (DMC), formerly Dynamic Materials Corp is an industrial equipment and machinery company. It manufactures, distributes, and markets explosion welded clad metal plates. The company’s products include oilfield products, explosive metalworking equipment, and AMK welding equipment, …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)-医療機器分野:企業M&A・提携分析
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • Enercon GmbH:電力:M&Aディール及び事業提携情報
    Summary Enercon GmbH (Enercon) is a renewable energy equipment company that manufactures and supplies wind energy converters (WEC). It produces components of the WECs including annular generators, inverters, rotor blades, cast components, towers and machine houses. Enercon provides electrical and me …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tokyo Gas Co Ltd (9531):電力:M&Aディール及び事業提携情報
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • The Save Mart Companies:戦略・SWOT・企業財務分析
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Siemens AG (SIE):石油・ガス:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆